Avastin: FDA Revokes Approval of Blockbuster Drug For Treating Breast Cancer

Published on
November 18, 2011

breast cancer, Avastin, reporting on health

Breast Cancer: The FDA revoked approval of Avastin as a breast cancer treatment, saying the blockbuster drug is unsafe and ineffective for that type of cancer, Rob Stein reports for the Washington Post.

Health Insurance: In the Wall St. Journal, Kristen Gerencher examines the challenges facing small businesses as they try to cobble together health insurance offerings for their workers.

Nutrition: In a small victory for nutrition advocates, the USDA opposes the fast-food conglomerate Yum Brands' campaign to allow food stamps to be allowed in its Taco Bell and KFC restaurants and is urging state governments to block such use, Leslie Patton reports for Bloomberg News.

Asthma: Sen. Rand Paul makes the startling – and incorrect – claim that air pollution is not connected to asthma, despite considerable scientific evidence to the contrary, Dina Cappiello reports for the Associated Press.

STDS: Although syphilis infection rates have dropped for the first time in a decade, new CDC data shows, a staggering 19 million new sexually transmitted disease infections are reported in the U.S. each year at a cost of $17 billion, Julie Steenhuysen reports for Reuters Health.

Want more from Reporting on Health? Join us, sign up for our newsletter, like us on Facebook or follow us on Twitter. Check out our Tumblr, too!

Photo credit: Paul Falardeau via Flickr